HealthTree University: Therapies On The Horizon - Elranatamab
Therapies On The Horizon is a new course introducing the newest upcoming therapies being researched in multiple myeloma. Elranatamab is one of these upcoming therapies. It is a bi-specific T-cell engaging antibody and works by getting the patient's immune cells to attack cancer cells directly. It is an off-the-shelf treatment that can be given right when the patient needs it. Watch the video below for more information! You can watch the full course on HealthTree University.
42.01 Elranatamab
We’d like to thank our faculty who donated their time in creating these videos, including:
- Dan Vogl, MD, MSCE
- Guenther Koehne, MD, PHD
Want more?
We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
- Myeloma Basics Part 1
- Myeloma Basics Part 2
- Myeloma Basics Part 3
- Myeloma Care Basics
- Building Your Healthcare Team
- Becoming an Empowered Patient
- Starting Myeloma Treatment
- Know Your Therapy
- Know Your Labs: Blood and Urine Testing in Myeloma
- Autologous Stem Cell Transplant (ASCT)
- Precursor Conditions
- Relapsed and Refractory MM Treatment
- Classes of Drugs
- Immunotherapy
- Myeloma Bone Disease
- Imaging in Myeloma
- MRD Testing
- Basic Genetics and Cancer Biology
- Myeloma Genetics
- Types of Genetic Testing in Myeloma
- Specific Myeloma Genetics Mutations and Risk
- Precision Medicine
- Financial Advice for Myeloma Patients and Their Families
- Geriatric Care and Myeloma
- Myeloma Kidney Disease
- Amyloidosis
- Myeloma Basics (Spanish)
- COVID-19 and Multiple Myeloma
- Complementary and Integrated Therapy
- Allogeneic Stem Cell Transplant
- Survivorship
- Clinical Trials
- Understanding Basic Blood tests
- Myeloma Vaccines
